Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Algert Global LLC

Algert Global LLC raised its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 50.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,873 shares of the company’s stock after buying an additional 5,003 shares during the quarter. Algert Global LLC’s holdings in Prestige Consumer Healthcare were worth $1,024,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of PBH. Covestor Ltd increased its position in Prestige Consumer Healthcare by 21.6% during the 1st quarter. Covestor Ltd now owns 834 shares of the company’s stock worth $61,000 after purchasing an additional 148 shares in the last quarter. Evergreen Capital Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 5.4% during the second quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock worth $216,000 after buying an additional 160 shares in the last quarter. Miller Howard Investments Inc. NY grew its holdings in shares of Prestige Consumer Healthcare by 2.2% during the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock worth $534,000 after buying an additional 165 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the last quarter. Finally, Parallel Advisors LLC lifted its stake in shares of Prestige Consumer Healthcare by 42.5% during the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock valued at $44,000 after buying an additional 213 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.7 %

Shares of PBH opened at $68.83 on Friday. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $75.80. The firm has a market capitalization of $3.42 billion, a P/E ratio of 16.51, a price-to-earnings-growth ratio of 2.01 and a beta of 0.47. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The stock’s fifty day simple moving average is $71.13 and its 200 day simple moving average is $69.48.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. During the same quarter in the previous year, the business earned $1.06 EPS. The company’s revenue for the quarter was down 4.4% on a year-over-year basis. On average, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. DA Davidson lifted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, August 28th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.